QURE
USDuniQure N.V. Ordinary Shares
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$30.810
Máximo
$32.490
Mínimo
$28.500
Volumen
8.90M
Fundamentos de la Empresa
Capitalización de Mercado
1.9B
Industria
Biotecnología
País
Netherlands
Estadísticas de Negociación
Volumen Promedio
3.75M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
uniQure N.V. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (QURE)
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against uniQure N.V. ("uniQure" or the "Company") (NASDAQ:QURE). The investigation concerns whether the
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
Goldman Sachs Maintains Neutral on uniQure, Lowers Price Target to $38
Goldman Sachs analyst Salveen Richter maintains uniQure with a Neutral and lowers the price target from $56 to $38.
RBC Capital Maintains Outperform on uniQure, Lowers Price Target to $45
RBC Capital analyst Luca Issi maintains uniQure with a Outperform and lowers the price target from $65 to $45.
William Blair Downgrades uniQure to Market Perform
William Blair analyst Sami Corwin downgrades uniQure from Outperform to Market Perform.
HC Wainwright & Co. Maintains Buy on uniQure, Lowers Price Target to $70
HC Wainwright & Co. analyst Patrick R. Trucchio maintains uniQure with a Buy and lowers the price target from $110 to $70.
Chardan Capital Maintains Buy on uniQure, Lowers Price Target to $53
Chardan Capital analyst Daniil Gataulin maintains uniQure with a Buy and lowers the price target from $76 to $53.
Acciones Relacionadas
ALNY
Alnylam Pharmaceuticals Inc.
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)
NBTX
Nanobiotix S.A. American Depositary Shares
XXII
22nd Century Group Inc.
ALKS
Alkermes plc Ordinary Shares
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.